Therapeutic Asset Ratings

722 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Cyclophosphamide Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P4	BBB (75)
Busulphan Fanconi Anemia	Masonic Cancer Center, University of Minnesota	P2/3	BBB (74)
Monomethyl Fumarate Refractory Anemia	Masonic Cancer Center, University of Minnesota	P2	BBB (73)
Busulphan Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P4	BBB (72)
Cyclophosphamide Adult Acute Myeloid Leukemia in Remission	Masonic Cancer Center, University of Minnesota	P3	BBB (72)
Busulphan Recurrent Grade 1 Follicular Lymphoma	Masonic Cancer Center, University of Minnesota	P2/3	BBB (72)
AVOLVE Prostate Cancer	Masonic Cancer Center, University of Minnesota	P4	BB (71)
Fludarabine Recurrent Adult Burkitt Lymphoma	Masonic Cancer Center, University of Minnesota	P3	BB (71)
Monomethyl Fumarate Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	BB (71)
Monomethyl Fumarate Recurrent Marginal Zone Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (71)
Monomethyl Fumarate Relapsed T-Cell Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (71)
Busulphan Anemia	Masonic Cancer Center, University of Minnesota	P4	BB (70)
Cyclophosphamide Acute Undifferentiated Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (70)
FILGRASTIM Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (70)
Monomethyl Fumarate Recurrent Adult Burkitt Lymphoma	Masonic Cancer Center, University of Minnesota	P3	BB (70)
Romidepsin Fanconi Anemia	Masonic Cancer Center, University of Minnesota	P2/3	BB (70)
Busulphan Recurrent Marginal Zone Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (69)
TACROLIMUS Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	BB (69)
TACROLIMUS Recurrent Marginal Zone Lymphoma	Masonic Cancer Center, University of Minnesota	P2	BB (69)
ETOPOSIDE Classical Hodgkin Lymphoma	Masonic Cancer Center, University of Minnesota	P3	BB (68)
Fludarabine Natural Killer Cell Lymphoblastic Leukemia/Lymphoma	Masonic Cancer Center, University of Minnesota	P3	BB (68)
Fludarabine Natural Killer Cell Malignancies	Masonic Cancer Center, University of Minnesota	P3	BB (68)
Monomethyl Fumarate Recurrent Grade 1 Follicular Lymphoma	Masonic Cancer Center, University of Minnesota	P3	BB (68)
Rapamycin Chronic Myelogenous Leukemia	Masonic Cancer Center, University of Minnesota	P3	BB (68)
Treosulfan Myelodysplastic Syndrome	Masonic Cancer Center, University of Minnesota	P3	BB (68)

Showing 1 to 25 of 722 assets

PreviousPage 1 of 29Next